Overall survival outcomes with first-line continuous ibrutinib and fixed-duration ibrutinib-venetoclax treatments in patients with chronic lymphocytic leukemia: Comparison with an age-matched European population / Ghia, P.; Ysebaert, L.; Janssens, A.; Stilgenbauer, S.; Fouad, M.; Schioppa, C. A.; Hernandez-Rivas, J. -A.; Tedeschi, A.. - In: HEMASPHERE. - ISSN 2572-9241. - 9:10(2025). [10.1002/hem3.70246]
Overall survival outcomes with first-line continuous ibrutinib and fixed-duration ibrutinib-venetoclax treatments in patients with chronic lymphocytic leukemia: Comparison with an age-matched European population
Ghia P.
;
2025-01-01
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
